Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Data: Stacks ecosystem in Q1 2026, sBTC TVL reached 545 millions USD, Zest Protocol TVL rose to 75.9 millions USD

Data: Stacks ecosystem in Q1 2026, sBTC TVL reached 545 millions USD, Zest Protocol TVL rose to 75.9 millions USD

ChaincatcherChaincatcher2026/04/28 03:01
Show original

ChainCatcher reports that Stacks has released ecosystem data for the first quarter of 2026: the total value locked (TVL) of sBTC reached 545 million USD, and the deposit cap has been completely removed; the amount of funds actively deployed in decentralized finance (DeFi) within the Stacks protocol is 121 million USD, with Zest Protocol holding a TVL of 75.9 million USD, Granite at 26 million USD, and StackingDAO at 20 million USD.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

UBS is bullish on CoreWeave (CRWV.US): Initiates "Buy" rating, betting on the return of AI trading rotation.

UBS has initiated coverage of the emerging cloud service provider CoreWeave (CRWV.US) with a "Buy" rating and set a target price of $120.

智通财经2026/09/24 07:01

Sixth increase in six years! Disney(DIS.US) raises the monthly fee for Disney+ ad-free version by 13% to $21.49.

Walt Disney Company (DIS.US) is raising subscription prices for several of its streaming services in the U.S. market, marking the sixth price increase in six years, as the company aims to boost the profitability of its streaming business, which is crucial for Disney's future.

智通财经2026/09/24 06:51

Johnson & Johnson (JNJ.US) Tarlatamab to be included in China's priority review, aimed at inhibiting tumor formation and growth

On September 24, according to the CDE website, Johnson & Johnson’s (JNJ.US) talquetamab (Chinese brand name: Tuolike) is proposed to be included in priority review.

智通财经2026/09/24 06:51
Johnson & Johnson (JNJ.US) Tarlatamab to be included in China's priority review, aimed at inhibiting tumor formation and growth